These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 18932025

  • 21. The effect of blood vessel invasion on prognosis of operated stage I non-small cell lung cancer patients.
    Turhan K, Samancilar O, Cagirici U, Goksel T, Nart D, Cakan A, Cok G.
    Thorac Cardiovasc Surg; 2010 Feb; 58(1):28-31. PubMed ID: 20072973
    [Abstract] [Full Text] [Related]

  • 22. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM, Recht A, Nikolov M, Flickinger JC, Decamp MM.
    Cancer; 2009 Feb 15; 115(4):851-8. PubMed ID: 19140203
    [Abstract] [Full Text] [Related]

  • 23. [Assessment of surgery for stage IV non-small cell lung cancer].
    Yamada T, Tanahashi M, Moriyama T, Hikosaka Y, Yoshitomi H.
    Kyobu Geka; 2006 Jan 15; 59(1):4-10. PubMed ID: 16440677
    [Abstract] [Full Text] [Related]

  • 24. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
    Chang MY, Mentzer SJ, Colson YL, Linden PA, Jaklitsch MT, Lipsitz SR, Sugarbaker DJ.
    J Thorac Cardiovasc Surg; 2007 Oct 15; 134(4):850-6. PubMed ID: 17903494
    [Abstract] [Full Text] [Related]

  • 25. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung.
    Fujisawa T, Yamaguchi Y.
    Cancer; 1997 Feb 01; 79(3):474-81. PubMed ID: 9028357
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation of the prognosis of patients with stage I non-small cell lung cancer with respect to predicted postoperative lung function].
    Koizumi K, Tanaka S, Haraguchi S, Matsushima S, Gomibuchi M.
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Feb 01; 44(2):162-8. PubMed ID: 8717264
    [Abstract] [Full Text] [Related]

  • 27. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.
    Esendagli G, Bruderek K, Goldmann T, Busche A, Branscheid D, Vollmer E, Brandau S.
    Lung Cancer; 2008 Jan 01; 59(1):32-40. PubMed ID: 17825949
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
    Sakamoto M, Mikasa K, Hamada K, Konishi M, Maeda K, Yoshimoto E, Ueda K, Majima T, Sawaki M, Kita E, Narita N.
    Gan To Kagaku Ryoho; 1998 Dec 01; 25(14):2259-66. PubMed ID: 9881083
    [Abstract] [Full Text] [Related]

  • 30. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT.
    Clin Cancer Res; 2008 Aug 15; 14(16):5220-7. PubMed ID: 18698040
    [Abstract] [Full Text] [Related]

  • 31. Large cell carcinoma of the lung: a contribution on prognosis after potentially curative resection.
    Huwer H, Donie HW, Volkmer I, Seitz G.
    Thorac Cardiovasc Surg; 1991 Aug 15; 39(4):218-20. PubMed ID: 1658978
    [Abstract] [Full Text] [Related]

  • 32. Postoperative follow-up for patients with non-small cell lung cancer.
    Nakamura R, Kurishima K, Kobayashi N, Ishikawa S, Goto Y, Sakai M, Onizuka M, Ishikawa H, Satoh H, Hizawa N, Sato Y.
    Onkologie; 2010 Aug 15; 33(1-2):14-8. PubMed ID: 20164657
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma.
    Takanami I, Takeuchi K, Giga M.
    J Thorac Cardiovasc Surg; 2001 Jun 15; 121(6):1058-63. PubMed ID: 11385371
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immunohistochemistry-detected microscopic tumor spread affects outcome in en-bloc resection for T3-chest wall lung cancer.
    Mineo TC, Ambrogi V, Pompeo E, Baldi A.
    Eur J Cardiothorac Surg; 2007 Jun 15; 31(6):1120-4. PubMed ID: 17400469
    [Abstract] [Full Text] [Related]

  • 39. Effect of age on survival of clinical stage I non-small-cell lung cancer.
    Sigel K, Bonomi M, Packer S, Wisnivesky J.
    Ann Surg Oncol; 2009 Jul 15; 16(7):1912-7. PubMed ID: 19408051
    [Abstract] [Full Text] [Related]

  • 40. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03.
    Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, Minato K, Mio T, Fujita Y, Yonei T, Nakano K, Tsuboi M, Shibata K, Furuse K, Fukushima M.
    Eur J Cancer; 2009 Jul 15; 45(11):1950-8. PubMed ID: 19231158
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.